StreetInsider.com News Articles

Form SC TO-I/A UTAH MEDICAL PRODUCTS Filed by: UTAH MEDICAL PRODUCTS INC

Tue, 29 Sep 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260929/27123226.html

Form SC TO-C UTAH MEDICAL PRODUCTS Filed by: UTAH MEDICAL PRODUCTS INC

Fri, 25 Sep 2026 12:46:00 -0400

si-local-file:///var/storage/secattach/20260925/27106108.html

Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date

Fri, 25 Sep 2026 11:00:00 -0400

SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC at

https://www.sec.gov/Archives/edgar/data/706698/000109690626001428/0001096906-26-001428-index.html

The Offer is scheduled to expire at 5:00 p.m. New York City time, on October 7, unless extended by UTMD. October 7 is a Wednesday. Some of UTMD's previous announcements indicated incorrectly

Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date

Fri, 25 Sep 2026 11:00:00 -0400

https://www.sec.gov/Archives/edgar/data/706698/000109690626001428/0001096906-26-001428-index.html

The Offer is scheduled to expire at 5:00 p.m. New York City time, on October 7, unless extended by UTMD. October 7 is a Wednesday. Some of UTMD's previous announcements indicated incorrectly

Form SC TO-C UTAH MEDICAL PRODUCTS Filed by: UTAH MEDICAL PRODUCTS INC

Thu, 24 Sep 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260924/27102893.html

Utah Medical Products launches tender offer for shares at $75 each

Thu, 24 Sep 2026 16:47:31 -0400

Utah Medical Products, Inc. (NASDAQ: UTMD) has announced a tender offer to purchase up to 650,000 shares of its common stock at $75.00 per share, representing a 17% premium over the stock's average daily closing price during the past twelve months and a 21% premium over the average for the past twenty-four months.

The company's board of directors approved the offer but is not making a recommendation to stockholders on whether to tender their shares. The offer is scheduled to expire at 5:00 p.m. New York City time on October 7, unless extended.

According to the press release, UTMD's first-half 2026 sales

Utah Medical Products, Inc. Commences Tender Offer

Thu, 24 Sep 2026 16:45:00 -0400

SALT LAKE CITY, UT / ACCESS Newswire / September 24, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The $75.00 per share price represents a 17% premium over the average daily closing price of the stock during the last twelve months, and a 21% premium over the average daily closing price of the stock during the last twenty-four months.

The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter

Utah Medical Products, Inc. Commences Tender Offer

Thu, 24 Sep 2026 16:45:00 -0400

The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter

Form SC TO-I UTAH MEDICAL PRODUCTS Filed by: UTAH MEDICAL PRODUCTS INC

Thu, 24 Sep 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260924/27098414.html

Form SC TO-C UTAH MEDICAL PRODUCTS Filed by: UTAH MEDICAL PRODUCTS INC

Thu, 17 Sep 2026 06:01:00 -0400

si-local-file:///var/storage/secattach/20260917/27072199.html

Utah Medical Products launches tender offer for 20% of shares at $75

Tue, 15 Sep 2026 10:01:48 -0400

Utah Medical Products, Inc. (NASDAQ: UTMD) announced plans to repurchase up to 650,000 of its shares at $75.00 per share through a self-tender offer, representing approximately 20% of its currently outstanding shares.

The tender offer is set to commence September 22, 2026, and will expire 15 business days later, unless extended. Stockholders may tender shares on or before October 7, 2026. The company said the offering price is 17% above the average daily closing price over the past 12 months and 21% above the two-year average. The highest intraday trading price over the past two years was $75.75.

If the offer is

Utah Medical Products launches tender offer for 20% of shares at $75

Tue, 15 Sep 2026 10:01:48 -0400

If the offer is

UTMD Announces Self-Tender for 20% of Its Shares

Tue, 15 Sep 2026 10:00:00 -0400

SALT LAKE CITY, UT / ACCESS Newswire / September 15, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces today that it intends to repurchase at a price of $75.00 per share up to 650,000 of its shares, if tendered and not withdrawn by stockholders on or before October 7, representing approximately 20% of its currently outstanding shares. The offering price is 17% higher than the average daily closing price of UTMD shares trading in the open market during the last twelve months, and 21% higher than the average daily closing price of

UTMD Announces Self-Tender for 20% of Its Shares

Tue, 15 Sep 2026 10:00:00 -0400

Femcare acquires UK harm reduction firm Orion for £3.6M

Mon, 31 Aug 2026 09:01:10 -0400

Femcare Ltd., a wholly-owned subsidiary of Utah Medical Products, Inc. (NASDAQ: UTMD), has acquired Orion Medical Supplies Ltd., a United Kingdom-based assembler and distributor of harm reduction medical devices, for £3.6 million paid from cash reserves.

Orion, a private UK company since 2008, produces kits incorporating devices designed to reduce the spread of blood-borne infections, harmful drug litter, and overdose injuries. The company distributes primarily in the UK and Europe. The former owners decided to retire.

According to UTMD, the acquisition is expected to add approximately $6 million to its consolidated annual sales. The company said the primary financial benefit will come

Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK

Mon, 31 Aug 2026 09:00:00 -0400

SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of Utah Medical Products, Inc. (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.

ORION is a niche assembler and distributor, primarily in the UK and Europe, of Harm Reduction medical devices. Harm Reduction refers to programs and practices that aim to minimize negative health, social and legal impacts associated with drug use, drug policies and drug laws. ORION's kits incorporate devices that

Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK

Mon, 31 Aug 2026 09:00:00 -0400

Form SCHEDULE 13G/A UTAH MEDICAL PRODUCTS Filed by: BRANDES INVESTMENT PARTNERS, LP

Fri, 14 Aug 2026 13:34:00 -0400

si-local-file:///var/storage/secattach/20260814/26928465.html

Form SCHEDULE 13G/A UTAH MEDICAL PRODUCTS Filed by: BRANDES INVESTMENT PARTNERS, LP

Fri, 14 Aug 2026 13:34:00 -0400

si-local-file:///var/storage/secattach/20260814/26928465.html

Form SCHEDULE 13G/A UTAH MEDICAL PRODUCTS Filed by: RENAISSANCE TECHNOLOGIES LLC

Thu, 13 Aug 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260813/26921695.html

Form SCHEDULE 13G/A UTAH MEDICAL PRODUCTS Filed by: RENAISSANCE TECHNOLOGIES LLC

Thu, 13 Aug 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260813/26921695.html

Form 10-Q UTAH MEDICAL PRODUCTS For: Jun 30

Wed, 12 Aug 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260812/26911851.html

Form 10-Q UTAH MEDICAL PRODUCTS For: Jun 30

Wed, 12 Aug 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260812/26911851.html

Utah Medical Products (UTMD) Declares $0.31 Quarterly Dividend; 1.7% Yield

Tue, 04 Aug 2026 10:04:30 -0400

Utah Medical Products (NASDAQ: UTMD) declared a quarterly dividend of $0.31 per share, or $1.24 annualized.

The dividend will be payable on October 5, 2026, to stockholders of record on September 17, 2026, with an ex-dividend date of September 16, 2026.

The annual yield on the dividend is 1.7 percent.

For a dividend history and other dividend-related data on Utah Medical Products (UTMD) click here.

Utah Medical Products, Inc. Announces Quarterly Dividend

Tue, 04 Aug 2026 10:00:00 -0400

SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad